Schroder Investment Management Group Alkermes Plc. Transaction History
Schroder Investment Management Group
- $94.5 Billion
- Q3 2024
A detailed history of Schroder Investment Management Group transactions in Alkermes Plc. stock. As of the latest transaction made, Schroder Investment Management Group holds 74,933 shares of ALKS stock, worth $2.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74,933
Previous 248,391
69.83%
Holding current value
$2.1 Million
Previous $5.99 Million
64.97%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding ALKS
# of Institutions
364Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$817 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$533 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$365 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$355 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$258 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.61B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...